Marı́a Teresita Branham

This study shows that targeting nuclear DNA methylation can selectively reduce heteroplasmy in mitochondrial diseases by impairing high-heteroplasmy cells.

This study identifies ID4 as a driver of aggressive basal-like breast cancer and shows that its inhibition reduces tumor growth and metastasis, suggesting it as a therapeutic target.